Skip to content
Home
About us
Insights
Stocks
Compliance
Special Services
Contact
Language
EN
BR
EN
EN
BR
Tag:
Saúde Suplementar
Insights
Cade to Rule on Amil-Golden Cross Deal in Test of ANS Limits
June 26, 2026
Insights
Amil and Bradesco Gain Ground Among Health Operators as Hapvida Keeps Losing Members
June 5, 2026
Insights
Rede D’Or Looks Cheap, But Investors Want a Trigger
May 19, 2026
Insights
Hapvida treats asset sales as “a possibility” under investor pressure
April 6, 2026
Insights
ANS Restores Cancer Care at Oncoclínicas as Unimed Ferj Is Replaced in Emergency Overhaul
November 27, 2025
Loading Comments...
Write a Comment...
Email (Required)
Name (Required)
Website
